Rebirth 1975: Tore up the call-back order at the beginning

After convincing Li Linzhang, Zhou Yang was in a good mood.

Domestic assistance in the production of the small blue pill is of extraordinary significance to Yuanwei Company and the entire sickle project.

Right now, the little blue pill has just been launched on Hong Kong Island, and the entire market is still in a state of short supply.

Under such circumstances, no matter how high the output in China or Hong Kong Island is, it can be converted into valuable foreign exchange in the face of huge demand. This is definitely a rare opportunity to put money in a sack.

It's just that there are not many people in China who know how to produce the small blue pills. Except for Zhou Yang himself, only Li Linzhang has this ability.

If Li Linzhang could not be persuaded to come forward to guide the production of the little blue pill, then Zhou Yang would have to go to Yangcheng himself.

But the problem is that spring has just started in Saibei Province, whether it is the village or the research institute, there are too many places that need him, Zhou Yang really can't leave.

Therefore, after receiving Lu Zhengjun's call, Zhou Yang's first thought was to ask Li Linzhang to walk around.

It's just that he is not sure about this matter, but he knows how much Li Linzhang resists this kind of "unscrupulous" medicine.

As a professor of medicine, Li Linzhang has the modesty of the name and the aloofness of a cultured man. Although he made the little blue pill according to his idea, he is unwilling to have anything to do with this drug.

Seeing his evasive expression, Zhou Yang was really afraid that he would not be able to convince him.

Fortunately, Li Linzhang is an old comrade with a big picture. Although he still doesn't accept the medicine, he agreed to go to Yangcheng after learning that it was an order from the superior department.

This made Zhou Yang heave a sigh of relief!

Zhou Yang, who was in a good mood, did not choose to leave immediately. After the matter was settled, he immediately came to the nearby Saibei Medical Research Center, accompanied by Li Linzhang, Zhong Qi and others.

After learning that Zhou Yang was coming, Song Shi, Yang Chunhua, Duan Yingzhong and others all put down their work and rushed over. After all, this is the director of the Medical Research Center.

After walking around the research center, at Zhou Yang's request, a group of people came to the conference room of the research center, and a small-scale internal meeting began immediately.

The meeting room was crowded with people. Except for Zhou Yang, Song Shi, Yang Chunhua, Duan Yingzhong, Zhong Qi and others all arrived. Everyone formed an oval around Zhou Yang as the center.

After everyone arrived, Zhou Yang looked around for a week. Wherever his eyes passed, everyone fell silent instantly.

"Comrades, it has been almost a year since our Saibei Pharmaceutical Research Center was established. After this year's development, there are still great changes. I saw a lot of new faces when I came here this time. Some of them I can't call Come on the name, and ask Professor Song to tell us about the basic situation here!"

Although Zhou Yang is the director of this medical research center, in the past year or so, the number of times Zhou Yang has been here is very limited, and he can count it with a single slap.

And Song Shi, who is in charge of daily work, is a research-oriented scholar, and he doesn't want to disturb Zhou Yang unless there is something particularly important.

Therefore, Zhou Yang really doesn't know much about the situation in Saibei Medical Center.

Of course, Zhou Yang cannot be blamed for being irresponsible, mainly because medical research is completely different from research and development in other fields.

Since medicine is ultimately to be used by people, it is a major event related to the lives of thousands of people, so we are more cautious in research and development, which leads to a longer research and development cycle.

From the establishment of the project to the production of results and then to the application for drug listing, it may take two or three years if it is short, and it may be more than ten years or even decades if it is long.

And Zhou Yang's time is so precious, he really doesn't have so much time to devote himself to the field of medical research and development.

Hearing Zhou Yang's roll call, Deputy Director Song Shi coughed lightly, and then said, "Indeed, a lot of newcomers have come to our side recently, including Professor Tao, a pioneer in the research and development of hepatitis B vaccine in China, and the director of liver disease research at Jingcheng Medical College. Comrade Lu Xuefeng, as well as Comrades Hou Tianming and Li Bingyi from the Research Institute, now our team has grown a lot, and it is no longer the grassroots team before!"

"At present, our Saibei Research Center has 8 departments, 87 full-time employees, and 76 interns. It can be regarded as a medium-sized medical research center! In addition to personnel, finance, security and other departments, we also include 3 project teams and a It is directly affiliated to the health center that is open to the outside world!"

"So far, our pharmaceutical research and development center is researching two projects, one is the research and development of the second-generation hepatitis B vaccine, and the other is the research and development of the Haemophilus influenzae type b infection vaccine..."

After listening to Song Shi's brief report, Zhou Yang nodded involuntarily.

Although there are no other scientific research achievements here except for the little blue pill, but in terms of development momentum, it is still good.

"Professor Song, what is the progress of the two R&D projects here?" Zhou Yang asked immediately.

"The progress of the second-generation hepatitis B vaccine is relatively smooth. At present, we have successfully recombined yeast DNA to produce human hepatitis B surface antigen protein."

Then Song Shi said again: "Although the technology for cultivating antigenic proteins is not very stable at present, the experimental results are very good. The vaccine bred by this method has a strong preventive effect on hepatitis B virus. Our research direction is correct!"

Zhou Yang was also very happy to hear that the research team had bred the antigenic protein of hepatitis B. This meant that the research on the second-generation hepatitis B vaccine had made a major breakthrough.

After all, this is the most difficult step for the second-generation hepatitis B vaccine to overcome. As long as the research continues according to the current method, a new type of hepatitis B vaccine that surpasses blood-derived vaccines should soon be produced.

Thinking of this, Zhou Yang looked at Yang Chunhua at the bottom left, and said, "Professor Yang, you are the person in charge of the hepatitis B vaccine research team. How long do you think it will take for the new vaccine to complete clinical trials?"

"We are confident that we will complete the first phase of clinical trials within one year!"

Then Yang Chunhua explained again: "At present, we have produced some second-generation vaccines through laboratory cultivation, and have also conducted related tests. Overall, the effect is not bad, and it is several times stronger than blood-borne vaccines."

"However, due to some technical problems, we can only carry out small-scale production in the laboratory, and the failure rate is very high, and there is no large-scale production at all. Therefore, in the next time, we will conduct clinical trials while conducting clinical trials. We still need to further improve the process, and strive to achieve mass production of our new vaccine within one year!"

Hearing this, Zhou Yang felt slightly excited.

The importance of hepatitis B vaccine is self-evident, and the market prospect is even more amazing.

Now not only in our country, but for any country in the world, hepatitis B is a troublesome social problem. This disease is not only harmful, but also contagious.

Once a certain base is reached, it is easy to cause panic in the whole society. Zhou Yang has a deep understanding of this.

Although the blood-derived hepatitis B vaccine has come out, the price is too expensive. For example, in the Zeehawk, a single shot of hepatitis B vaccine is as high as more than 100 dollars, and the effect is not very good.

If Yang Chunhua and others can develop a real second-generation hepatitis B vaccine, let alone how much money they can make for the country, it will also be of great significance for us to control the high level of hepatitis B population in our country.

"Well, I believe you can do it, just ask for anything you need, and I will try my best to meet your requirements!" Zhou Yang said.

"Yes!"

"Professor Song, how is the project you are hosting going?" Zhou Yang asked again.

"I am leading the research on the Haemophilus influenzae type b infection vaccine. Last year, our research team has cultivated this virus in the laboratory, but the effect is not very good. There should be no way to produce results in a short time!" Song Shi sighed. Said in a tone.

"Don't worry, pharmaceutical research and development itself is slow work and meticulous work. If you are too anxious, you will not be able to eat hot tofu!"

Then Zhou Yang continued: "It just so happens that I have some research on Haemophilus influenzae type b infection, let's talk about it later!"

Hearing this, Song Shi's eyes lit up immediately, and an excited expression appeared on his face...

........

ps: Chapter 2 is delivered!